1. P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE PHASE 3 ECHELON-3 STUDY. (23rd June 2022) Authors: Bartlett, N. L.; Yasenchak, C. A.; Ashraf, K. K.; Harwin, W. N.; Orcutt, J.; Kuriakose, P.; Zinzani, P. L.; Mamidipalli, A.; Fenton, K.; Glenn, C.; Nowakowski, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1064 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗